US · biotech · biotechnology · epigenetic reprogramming
Who invested in NewLimit
3 rounds we have observed, with the investors named in each. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
The rounds
Series C · Jun 2026 · $435M
Founders Fund lead, Thrive Capital, Greenoaks, Quiet Capital
Reported by Ventureburn
Undisclosed round · Oct 2025 · $45M
Kleiner Perkins, Abstract, Human Capital, Section 32, Boost VC, Dimension, Duke University, Lilly Ventures
Reported by Ventureburn
Series B · May 2025 · $130M
Kleiner Perkins lead, Khosla Ventures, Founders Fund, Valor Equity Partners, Elad Gil, Human Capital, Nat Friedman, Patrick Collison, Dimension, Garry Tan, Daniel Gross, Dimension Capital, Joe Lonsdale, Brian Armstrong, Fred Ehrsam, John & Patrick Collison, Joshua Kushner
Reported by TechCrunch and 1 other · SEC filing: $130M sold under the offering, first sale May 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.